Precision medicine selection with MyPathway for solid tumours
Precision medicine selection with MyPathway for solid tumours
Liquid biopsy may help guide treatment decisions for advanced solid tumours
ASCO 2016: Expert discussion on the latest on multiple myeloma
Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin
Hypo-fractionation of prostate cancer radiotherapy
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma
Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin
Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer
Temozolomide after radiotherapy improves glioma survival
Mechanistic studies of DNA repair
Oncology for children: what can be done when resources are scarce?
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates